Acidic Sphingomyelinase (ASM) Is Necessary for Fas-induced GD3 Ganglioside Accumulation and Efficient Apoptosis of Lymphoid Cells
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Ceramides deriving from sphingomyelin hydrolysis are important mediators of apoptotic signals originating from Fas (APO-1/CD95). However, definitive evidence for the role played by individual sphingomyelinases is still lacking. We have analyzed lymphoblastoid cell lines derived from patients affected by Niemann Pick disease (NPD), an autosomal recessive disorder caused by loss-of-function mutations within the acidic sphingomyelinase (ASM) gene. NPD lymphoblasts, which display normal neutral sphingomyelinase activity, fail to activate ASM in response to Fas cross-linking, unlike normal lymphoblasts. NPD lymphoblasts also fail to accumulate GD3 ganglioside, a downstream mediator of ceramide-induced cell death (De Maria, R., L. Lenti, F. Malisan, F. D'Agostino, B. Tomassini, A. Zeuner, M.R. Rippo, R. Testi. 1997. Science. 277:1652–1655), and display a substantially inefficient apoptosis after Fas cross-linking. Inefficient apoptosis is due to lack of ASM activity, because proximal signaling from Fas in NPD lymphoblasts is not impaired and apoptosis can be efficiently triggered by passing the ASM defect with exogenous ceramides. Moreover, mannose receptor–mediated transfer of ASM into NPD lymphoblasts rescues their ability to transiently activate ASM, accumulate GD3, and rapidly undergo apoptosis after Fas cross-linking. These results provide definitive genetic evidence for the role of ASM in the progression of apoptotic signals originating from Fas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81266-0 · Cited by 3,046 · cited 1×
“Seconds after receptor engagement, caspase 8 (FLICE/MACH-1/ MCH5), a member of the ICE/CED-3 family of cysteine proteases, is recruited to the receptor “death domain” via the adaptor molecule FADD/MORT1, and is activated (3, 4).”
Background
Cited by
MATURE T LYMPHOCYTE APOPTOSIS—Immune Regulation in a Dynamic and Unpredictable Antigenic Environment
Lenardo, M., Chan, F. K.-M., Hornung, F., McFarland, H., Siegel, R., Wang, J., & Zheng, L. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.221 · Cited by 943
Cell death modalities: classification and pathophysiological implications
Galluzzi, L., Maiuri, M. C., Vitale, I., Zischka, H., Castedo, M., Zitvogel, L., & Kroemer, G. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402148 · Cited by 832
Signal transduction of stress via ceramide
MATHIAS, S., PEÑA, L. A., & KOLESNICK, R. N. (1998) · Biochemical Journal · doi:10.1042/bj3350465 · Cited by 682
Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
Peter, M. E., & Krammer, P. H. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80222-7 · Cited by 498
Ceramide: second messenger or modulator of membrane structure and dynamics?
BLITTERSWIJK, W. J. V., LUIT, A. H. V. D., VELDMAN, R. J., VERHEIJ, M., & BORST, J. (2003) · Biochemical Journal · doi:10.1042/bj20021528 · Cited by 435
Ceramide Enables Fas to Cap and Kill
Cremesti, A., Paris, F., Grassmé, H., Holler, N., Tschopp, J., Fuks, Z., Gulbins, E., & Kolesnick, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101866200 · Cited by 380
Cathepsin D targeted by acid sphingomyelinase-derived ceramide
Heinrich, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5252 · Cited by 365
Acid and neutral sphingomyelinases: roles and mechanisms of regulation
Marchesini, N., & Hannun, Y. A. (2004) · Biochemistry and Cell Biology · doi:10.1139/o03-091 · Cited by 339
Levade, T., & Jaffrézou, J.-P. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(99)00038-4 · Cited by 299
Regulation of TNFR1 and CD95 signalling by receptor compartmentalization
Schütze, S., Tchikov, V., & Schneider-Brachert, W. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2430 · Cited by 297
Ceramide in apoptosis signaling: relationship with oxidative stress
Andrieu-Abadie, N., Gouazé, V., Salvayre, R., & Levade, T. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00655-4 · Cited by 279
Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses
Choi, C., & Benveniste, E. N. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2003.08.007 · Cited by 270
García‐Ruiz, C., Colell, A., París, R., & Fernández‐Checa, J. C. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.847 · Cited by 197
Ceramide in apoptosis—does it really matter?
Hofmann, K., & Dixit, V. M. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01289-4 · Cited by 185
Okada, M., Itoh, M.-I., Haraguchi, M., Okajima, T., Inoue, M., Oishi, H., Matsuda, Y., Iwamoto, T., Kawano, T., Fukumoto, S., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100395200 · Cited by 179
Regulation of death receptor signaling and apoptosis by ceramide
Gulbins, E. (2003) · Pharmacological Research · doi:10.1016/s1043-6618(03)00052-5 · Cited by 163
Metadata
- Authors
- De Maria, R., Rippo, M. R., Schuchman, E. H., & Testi, R.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1998-03-16
- Volume
- 187
- Issue
- 6
- Pages
- 897-902
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2130007939
- Cited by
- 148
- References
- 2
- FWCI
- 6.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.